154 related articles for article (PubMed ID: 36350492)
1. Temporal muscle thickness as an independent prognostic marker in glioblastoma patients-a systematic review and meta-analysis.
Sadhwani N; Aggarwal A; Mishra A; Garg K
Neurosurg Rev; 2022 Dec; 45(6):3619-3628. PubMed ID: 36350492
[TBL] [Abstract][Full Text] [Related]
2. Prognostic relevance of temporal muscle thickness as a marker of sarcopenia in patients with glioblastoma at diagnosis.
Muglia R; Simonelli M; Pessina F; Morenghi E; Navarria P; Persico P; Lorenzi E; Dipasquale A; Grimaldi M; Scorsetti M; Santoro A; Politi LS
Eur Radiol; 2021 Jun; 31(6):4079-4086. PubMed ID: 33201284
[TBL] [Abstract][Full Text] [Related]
3. Temporal muscle thickness is an independent prognostic marker in patients with progressive glioblastoma: translational imaging analysis of the EORTC 26101 trial.
Furtner J; Genbrugge E; Gorlia T; Bendszus M; Nowosielski M; Golfinopoulos V; Weller M; van den Bent MJ; Wick W; Preusser M
Neuro Oncol; 2019 Dec; 21(12):1587-1594. PubMed ID: 31369680
[TBL] [Abstract][Full Text] [Related]
4. A novel radiographic marker of sarcopenia with prognostic value in glioblastoma.
Huq S; Khalafallah AM; Ruiz-Cardozo MA; Botros D; Oliveira LAP; Dux H; White T; Jimenez AE; Gujar SK; Sair HI; Pillai JJ; Mukherjee D
Clin Neurol Neurosurg; 2021 Aug; 207():106782. PubMed ID: 34186275
[TBL] [Abstract][Full Text] [Related]
5. Association between temporal muscle thickness and clinical outcomes in patients with newly diagnosed glioblastoma.
An G; Ahn S; Park JS; Jeun SS; Hong YK
J Cancer Res Clin Oncol; 2021 Mar; 147(3):901-909. PubMed ID: 32929611
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of temporal muscle thickness, a novel radiographic marker of sarcopenia, in patients with brain tumor: A systematic review and meta-analysis.
Yang YW; Ming Yang ; Zhou YW; Xia X; Jia SL; Zhao YL; Zhou LX; Cao Y; Ge ML
Nutrition; 2023 Aug; 112():112077. PubMed ID: 37236042
[TBL] [Abstract][Full Text] [Related]
7. The possible relation between temporal muscle mass and glioblastoma multiforme prognosis via sarcopenia perspective.
Sütcüoğlu O; Erdal ZS; Akdoğan O; Çeltikçi E; Özdemir N; Özet A; Uçar M; Yazıcı O
Turk J Med Sci; 2023 Feb; 53(1):413-419. PubMed ID: 36945944
[TBL] [Abstract][Full Text] [Related]
8. Temporalis muscle thickness as an indicator of sarcopenia predicts progression-free survival in head and neck squamous cell carcinoma.
Lee B; Bae YJ; Jeong WJ; Kim H; Choi BS; Kim JH
Sci Rep; 2021 Oct; 11(1):19717. PubMed ID: 34611230
[TBL] [Abstract][Full Text] [Related]
9. Correlation of reduced temporal muscle thickness and systemic muscle loss in newly diagnosed glioblastoma patients.
Ten Cate C; Huijs SMH; Willemsen ACH; Pasmans RCOS; Eekers DBP; Zegers CML; Ackermans L; Beckervordersandforth J; van Raak EPM; Anten MHME; Hoeben A; Postma AA; Broen MPG
J Neurooncol; 2022 Dec; 160(3):611-618. PubMed ID: 36394717
[TBL] [Abstract][Full Text] [Related]
10. Is temporal muscle thickness a survival predictor in newly diagnosed glioblastoma multiforme?
Yesil Cinkir H; Colakoglu Er H
Asia Pac J Clin Oncol; 2020 Oct; 16(5):e223-e227. PubMed ID: 32762134
[TBL] [Abstract][Full Text] [Related]
11. Temporal Muscle Thickness as a Prognostic Marker in Patients with Newly Diagnosed Glioblastoma: Translational Imaging Analysis of the CENTRIC EORTC 26071-22072 and CORE Trials.
Furtner J; Weller M; Weber M; Gorlia T; Nabors B; Reardon DA; Tonn JC; Stupp R; Preusser M;
Clin Cancer Res; 2022 Jan; 28(1):129-136. PubMed ID: 34667022
[TBL] [Abstract][Full Text] [Related]
12. Survival prediction using temporal muscle thickness measurements on cranial magnetic resonance images in patients with newly diagnosed brain metastases.
Furtner J; Berghoff AS; Albtoush OM; Woitek R; Asenbaum U; Prayer D; Widhalm G; Gatterbauer B; Dieckmann K; Birner P; Aretin B; Bartsch R; Zielinski CC; Schöpf V; Preusser M
Eur Radiol; 2017 Aug; 27(8):3167-3173. PubMed ID: 28050694
[TBL] [Abstract][Full Text] [Related]
13. The association of BMI and sarcopenia with survival in patients with glioblastoma multiforme.
Guven DC; Aksun MS; Cakir IY; Kilickap S; Kertmen N
Future Oncol; 2021 Nov; 17(32):4405-4413. PubMed ID: 34409854
[No Abstract] [Full Text] [Related]
14. Advances in the relationship between temporal muscle thickness and prognosis of patients with glioblastoma: a narrative review.
Tang J; Dong Z; Sheng J; Yang P; Zhao W; Xue J; Li Q; Lv L; Lv X
Front Oncol; 2023; 13():1251662. PubMed ID: 37771443
[TBL] [Abstract][Full Text] [Related]
15. Impact of temporalis muscle thickness in elderly patients with newly diagnosed glioblastoma treated with radio or radio-chemotherapy.
Pasqualetti F; Gabelloni M; Gonnelli A; Faggioni L; Cantarella M; Montrone S; Gadducci G; Giannini N; Montemurro N; Mattioni R; Perrini P; Morganti R; Cosottini M; Neri E; Paiar F
Radiol Med; 2022 Aug; 127(8):919-924. PubMed ID: 35849309
[TBL] [Abstract][Full Text] [Related]
16. The prognostic utility of temporalis muscle thickness measured on magnetic resonance scans in patients with intra-axial malignant brain tumours: A systematic review and meta-analysis.
Olukoya O; Osunronbi T; Jesuyajolu DA; Uwaga BC; Vaughan A; Aluko O; Ayantayo TO; Daniel JOI; David SO; Jagunmolu HA; Kanu A; Kayode AT; Olajide TN; Thorne L
World Neurosurg X; 2024 Apr; 22():100318. PubMed ID: 38440376
[TBL] [Abstract][Full Text] [Related]
17. Association between Temporal Muscle Thickness and Overall Survival in Non-Small Cell Lung Cancer Patients with Brain Metastasis.
Kim YI; Shin JY; Yang SH; Kim HH; Shim BY; Ahn S
Curr Oncol; 2022 Sep; 29(9):6463-6471. PubMed ID: 36135077
[TBL] [Abstract][Full Text] [Related]
18. Temporal muscle thickness as an independent prognostic imaging marker in newly diagnosed glioblastoma patients: A validation study.
Broen MPG; Beckers R; Willemsen ACH; Huijs SMH; Pasmans RCOS; Eekers DBP; Ackermans L; Beckervordersandforth J; van Raak EPM; Verduin M; Anten MHME; Hoeben A; Postma AA
Neurooncol Adv; 2022; 4(1):vdac038. PubMed ID: 35475275
[TBL] [Abstract][Full Text] [Related]
19. Temporal muscle thickness is an independent prognostic marker in melanoma patients with newly diagnosed brain metastases.
Furtner J; Berghoff AS; Schöpf V; Reumann R; Pascher B; Woitek R; Asenbaum U; Pelster S; Leitner J; Widhalm G; Gatterbauer B; Dieckmann K; Höller C; Prayer D; Preusser M
J Neurooncol; 2018 Oct; 140(1):173-178. PubMed ID: 30008154
[TBL] [Abstract][Full Text] [Related]
20. Temporal Muscle Thickness Correlates with Sarcopenia in Parkinson's Disease.
Peball M; Valent D; Grossauer A; Marini K; Ellmerer P; Wallnöfer J; Krismer F; Djamshidian A; Seppi K; Heim B
J Parkinsons Dis; 2023; 13(3):341-350. PubMed ID: 37005894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]